|
1
|
Chen JD, Yang HI, Iloeje UH, You SL, Lu
SN, Wang LY, Su J, Sun CA, Liaw YF and Chen CJ; Risk Evaluation of
Viral Load Elevation and Associated Liver Disease/Cancer in HBV
(REVEAL-HBV) Study Group, : Carriers of inactive hepatitis B virus
are still at risk for hepatocellular carcinoma and liver-related
death. Gastroenterology. 138:1747–1754. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Petruzziello A: Epidemiology of Hepatitis
B Virus (HBV) and Hepatitis C Virus (HCV) related hepatocellular
carcinoma. Open Virol J. 12:26–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jing L, Liang H, Yan J, Qiu M and Yan Y:
Liver resection for hepatocellular carcinoma: Personal experiences
in a series of 1330 consecutive cases in China. ANZ J Surg.
88:E713–E717. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Costa FF: Non-coding RNAs: Meet thy
masters. Bioessays. 32:599–608. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sagnelli E, Potenza N, Onorato L, Sagnelli
C, Coppola N and Russo A: Micro-RNAs in hepatitis B virus-related
chronic liver diseases and hepatocellular carcinoma. World J
Hepatol. 27:558–570. 2018. View Article : Google Scholar
|
|
6
|
Rana MA, Ijaz B, Daud M, Tariq S, Nadeem T
and Husnain T: Interplay of Wnt β-catenin pathway and miRNAs in HBV
pathogenesis leading to HCC. Clin Res Hepatol Gastroenterol.
43:373–386. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gong X, Wei W, Chen L, Xia Z and Yu C:
Comprehensive analysis of long non-coding RNA expression profiles
in hepatitis B virus-related hepatocellular carcinoma. Oncotarget.
7:42422–42430. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu TT, Xu XM, Hu Y, Deng JJ, Ge W, Han NN
and Zhang MX: Long noncoding RNAs in hepatitis B
virus-relatedhepatocellular carcinoma. World J Gastroenterol.
21:7208–7217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du J, Bai F, Zhao P, Li X, Li X, Gao L, Ma
C and Liang X: Hepatitis B core protein promotes liver cancer
metastasis through miR-382-5p/DLC-1 axis. Biochim Biophys Acta Mol
Cell Res. 1865:1–11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li G, Zhang W, Gong L and Huang X:
MicroRNA-125a-5p Inhibits Cell Proliferation and Induces Apoptosis
in Hepatitis B Virus-Related Hepatocellular Carcinoma by
Downregulation of ErbB3. Oncol Res. 27:449–458. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu N, Liu Q, Yang X, Zhang F, Li X, Ma Y,
Guan F, Zhao X, Li Z, Zhang L and Ye X: Hepatitis B
virus-upregulated lnc-HUR1 promotes cell proliferation and
tumorigenesis by blocking p53 activity. Hepatology. 68:2130–2144.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin Y, Wu D, Yang W, Weng M, Li Y, Wang X,
Zhang X, Jin X and Wang T: Hepatitis B virus × protein induces
epithelial-mesenchymal transition of hepatocellular carcinoma cells
by regulating long non-coding RNA. Virol J. 14:2382017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Liu G, Li X, Dong H, Xiao W and Lu
S: Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma
progression through regulation of miR-140-5p-TGFBR1 pathway.
Biochem Biophys Res Commun. 503:2826–2832. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sui J, Yang X, Qi W, Guo K, Gao Z, Wang L
and Sun D: Long non-coding RNA linc-USP16 functions as a tumour
suppressor in hepatocellular carcinoma by regulating PTEN
expression. Cell Physiol Biochem. 44:1188–1198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv J, Fan HX, Zhao XP, Lv P, Fan JY, Zhang
Y, Liu M and Tang H: Long non-coding RNA unigene56159 promotes
epithelial-mesenchymal transition by acting as a ceRNA of
miR-140-5p in hepatocellular carcinoma cells. Cancer Lett.
382:166–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan H, Lv P, Mu T, Zhao X, Liu Y, Feng Y,
Lv J, Liu M and Tang H: LncRNA n335586/miR-924/CKMT1A axis
contributes to cell migration and invasion in hepatocellular
carcinoma cells. Cancer Lett. 429:89–99. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang F, Zhang L, Huo XS, Yuan JH, Xu D,
Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, et al: Long noncoding
RNA high expression in hepatocellular carcinoma facilitates tumor
growth through enhancer of zeste homolog 2 in humans. Hepatology.
54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Y, Chen L, Gu J, Zhang H, Yuan J,
Lian Q, Lv G, Wang S, Wu Y, Yang YT, et al: Recurrently deregulated
lncRNAs in hepatocellular carcinoma. Nat Commun. 8:144212017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Diboun I, Wernisch L, Orengo CA and
Koltzenburg M: Microarray analysis after RNA amplification can
detect pronounced differences in gene expression using limma. BMC
Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carvalho B, Bengtsson H, Speed TP and
Irizarry RA: Exploration, normalization, and genotype calls of
high-density oligonucleotide SNP array data. Biostatistics.
8:485–499. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nikolayeva O and Robinson MD: edgeR for
differential RNA-seq and ChIP-seq analysis: An application to stem
cell biology. Methods Mol Biol. 1150:45–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM and Hatzigeorgiou
AG: DIANA-LncBase: Experimentally verified and computationally
predicted microRNA targets on long non-coding RNAs. Nucleic Acids
Res. 41:D239–D245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Davis AP, Grondin CJ, Johnson RJ, Sciaky
D, King BL, McMorran R, Wiegers J, Wiegers TC and Mattingly CJ: The
comparative toxicogenomics database: Update 2017. Nucleic Acids
Res. 45:D972–D978. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lan T, Ma W, Hong Z, Wu L, Chen X and Yuan
Y: Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12)
promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in
hepatocellular carcinoma. J Exp Clin Cancer Res. 36:112017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X, Li B, Ran P and Wang L:
Identification of ceRNA network based on a RNA-seq shows prognostic
lncRNA biomarkers in human lung adenocarcinoma. Oncol Lett.
16:5697–5708. 2018.PubMed/NCBI
|
|
28
|
Lauper N, Beck AR, Cariou S, Richman L,
Hofmann K, Reith W, Slingerland JM and Amati B: Cyclin E2: A novel
CDK2 partner in the late G1 and S phases of the mammalian cell
cycle. Oncogene. 17:2637–2643. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Payton M, Scully S, Chung G and Coats S:
Deregulation of cyclin E2 expression and associated kinase activity
in primary breast tumors. Oncogene. 21:8529–8534. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kumari S, Puneet, Prasad SB, Yadav SS,
Kumar M, Khanna A, Dixit VK, Nath G, Singh S and Narayan G: Cyclin
D1 and cyclin E2 are differentially expressed in gastric cancer.
Med Oncol. 33:402016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie L, Li T and Yang LH: E2F2 induces
MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts
poor overall survival. Eur Rev Med Pharmacol Sci. 21:2150–2156.
2017.PubMed/NCBI
|
|
32
|
Hu J, Qiao M, Chen Y, Tang H, Zhang W,
Tang D, Pi S, Dai J, Tang N, Huang A and Hu Y: Cyclin E2-CDK2
mediate SAMHD1 phosphorylation to abrogate its restriction of HBV
replication in hepatoma cells. FEBS Lett. 592:1893–1904. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Morikawa T, Hino R, Uozaki H, Maeda D,
Ushiku T, Shinozaki A, Sakatani T and Fukayama M: Expression of
ribonucleotide reductase M2 subunit in gastric cancer and effects
of RRM2 inhibition in vitro. Hum Pathol. 41:1742–1748. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhong Z, Cao Y, Yang S and Zhang S:
Overexpression of RRM2 in gastric cancer cell promotes their
invasiveness via AKT/NF-κB signaling pathway. Pharmazie.
71:280–284. 2016.PubMed/NCBI
|
|
35
|
Wang N, Zhan T, Ke T, Huang X, Ke D, Wang
Q and Li H: Increased expression of RRM2 by human papillomavirus E7
oncoprotein promotes angiogenesis in cervical cancer. Br J Cancer.
110:1034–1044. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang J, Ma J, Wang H, Guo L and Li J:
Serum microRNA-30c levels are correlated with disease progression
in Xinjiang Uygur patients with chronic hepatitis B. Braz J Med
Biol Res. 50:e60502017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tormo E, Adam-Artigues A, Ballester S,
Pineda B, Zazo S, González-Alonso P, Albanell J, Rovira A, Rojo F,
Lluch A and Eroles P: The role of miR-26a and miR-30b in HER2 +
breast cancer trastuzumab resistance and regulation of the CCNE2
gene. Sci Rep. 7:413092017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Arima C, Kajino T, Tamada Y, Imoto S,
Shimada Y, Nakatochi M, Suzuki M, Isomura H, Yatabe Y, Yamaguchi T,
et al: Lung adenocarcinoma subtypes definable by lung
development-related miRNA expression profiles in association with
clinicopathologic features. Carcinogenesis. 35:2224–2231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ramnarine VR, Alshalalfa M, Mo F, Nabavi
N, Erho N, Takhar M, Shukin R, Brahmbhatt S, Gawronski A, Kobelev
M, et al: The long noncoding RNA landscape of neuroendocrine
prostate cancer and its clinical implications. Gigascience.
7:giy0502018. View Article : Google Scholar :
|
|
40
|
Yang J, AlTahan AM, Hu D, Wang Y, Cheng
PH, Morton CL, Qu C, Nathwani AC, Shohet JM, Fotsis T, et al: The
role of histone demethylase KDM4B in Myc signaling in
neuroblastoma. J Natl Cancer Inst. 107:djv0802015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ivanov S, Liao SY, Ivanova A,
Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ,
Proescholdt MA, Oldfield EH, Lee J, et al: Expression of
hypoxia-inducible cell-surface transmembrane carbonic anhydrases in
human cancer. Am J Pathol. 158:905–919. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hussain SA, Ganesan R, Reynolds G, Gross
L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS,
Billingham L, et al: Hypoxia-regulated carbonic anhydrase IX
expression is associated with poor survival in patients with
invasive breast cancer. Br J Cancer. 96:104–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang DB, Lu XK, Zhang X, Li ZG and Li CX:
Carbonic anhydrase 1 is a promising biomarker for early detection
of non-small cell lung cancer. Tumour Biol. 37:553–559. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kazokaitė J, Ames S, Becker HM, Deitmer JW
and Matulis D: Selective inhibition of human carbonic anhydrase IX
in Xenopus oocytes and MDA-MB-231 breast cancer cells. J Enzyme
Inhib Med Chem. 31:38–44. 2016. View Article : Google Scholar
|
|
45
|
Parkkila S, Rajaniemi H, Parkkila AK,
Kivela J, Waheed A, Pastorekova S, Pastorek J and Sly WS: Carbonic
anhydrase inhibitor suppresses invasion of renal cancer cells in
vitro. Proc Natl Acad Sci USA. 97:2220–2224. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tachibana H, Gi M, Kato M, Yamano S,
Fujioka M, Kakehashi A, Hirayama Y, Koyama Y, Tamada S, Nakatani T
and Wanibuchi H: Carbonic anhydrase 2 is a novel
invasion-associated factor in urinary bladder cancers. Cancer Sci.
108:331–337. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nortunen M, Huhta H, Helminen O, Parkkila
S, Kauppila JH, Karttunen TJ and Saarnio J: Carbonic anhydrases II,
IX, and XII in Barrett's esophagus and adenocarcinoma. Virchows
Arch. 473:567–575. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang C, Wang H, Chen Z, Zhuang L, Xu L,
Ning Z, Zhu Z, Wang P and Meng Z: Carbonic anhydrase 2 inhibits
epithelial-mesenchymal transition and metastasis in hepatocellular
carcinoma. Carcinogenesis. 39:562–570. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhao C, Li Y, Chen G, Wang F, Shen Z and
Zhou R: Overexpression of miR-15b-5p promotes gastric cancer
metastasis by regulating PAQR3. Oncol Rep. 38:352–358. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen R, Sheng L, Zhang HJ, Ji M and Qian
WQ: miR-15b-5p facilitates the tumorigenicity by targeting RECK and
predicts tumour recurrence in prostate cancer. J Cell Mol Med.
22:1855–1863. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen Y, Chen J, Liu Y, Li S and Huang P:
Plasma miR-15b-5p, miR-338-5p, and miR-764 as biomarkers for
hepatocellular carcinoma. Med Sci Monit. 21:1864–1871. 2015.
View Article : Google Scholar : PubMed/NCBI
|
